The construction of a novel xenograft bovine bone scaffold, (DSS)6-liposome/CKIP-1 siRNA/calcine bone and its osteogenesis evaluation on skull defect in rats

Abstract

Background Xenograft bone scaffolds have advantages such as mechanical strength, sufficient source and safety. Combined with siRNA properly targeting CKIP-1, a negative regulator of osteogenesis, may contribute to the repair result of calcine bone alone. Methods Herein, we constructed a novel xenograft bovine bone scaffold namely (DSS)6-liposome/CKIP-1 siRNA/calcine bone, the characteristics of which were investigated by confirming the effect of (DSS)6-liposome, observing the appearance and testing mechanical strength of calcine bone, and observing the combined result of CKIP-1 siRNA by FAM immunofluorescence. In addition, cytotoxicity by CCK-8 and LDH activity of L929 ​cells and MC3T3-E1 osteoblasts cultured with the scaffold were tested in vitro, primary osteoblasts proliferation, the mRNA expressions of CKIP-1, ALP, COL1-α and OCN, the protein expressions of CKIP-1, BMP-2, COL-1 and Runx2 and calcium nodules were also determined by CCK-8, RT-qPCR, western-blot and Alizarin Red staining in vitro. Then, we successively established the skull defect model for evaluating the repair result of the novel scaffold by HE staining of 2, 4, 8 and 12 weeks, immumohistochemical stainings of 2, 4, 8 and 12 weeks such as ALP, COL-1α and OCN, Mirco-CT scanning of 4 and 12 weeks and the relative parameters and so on in vivo. Results It indicated that (DSS)6-liposome/CKIP-1 siRNA/calcine bone could successfully knock down the CKIP-1 mRNA and protein expressions, promote osteoblasts proliferation with the little cytotoxicity in vitro, increase the protein expressions of BMP-2, COL-1 and Runx2 in vitro, increase mRNA expressions of ALP, COL-1α and OCN in vitro and in vivo, and have a better bone defect repair effect with few side effects in rats after 12 weeks. Conclusion Our research indicates (DSS)6-liposome/CKIP-1 siRNA/calcine bone could repair skull defects well in rats, and it may lay the foundation of applicating the novel xenograft bone scaffold in the clinical. The Translational potential of this article These findings provide evidence that (DSS)6- liposome/CKIP-1 siRNA/calcine bone could be used as a novel xenograft bone scaffold for osteogenesis with the good safety.

Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis

“…RT-qPCR was conducted as previously described. 46 Briefly, total RNA from each sample was extracted using TRIzol reagent and reverse transcribed with a Script™ Reverse Transcription Kit (A276A, Promega). SYBR Green qPCR Master Mix (B21202, Bimake) was used for RT–qPCR with a 7500 real-time PCR instrument (Thermo Fisher Scientific).…”

Hope for bone regeneration: The versatility of iron oxide nanoparticles

“…SCs labeled by IOPNs can migrate and home to specific sites in response to magnetic fields. It has been disclosed that the presence of SPIONs confers special magnetic properties to PLGA microspheres, which greatly promote the proliferation, migration, and osteogenic differentiation of BMSCs under the influence of external magnetic fields (Zhao et al, 2021). Moreover, the combination of pulsed electromagnetic fields (PEMF) and SPIONs were synergistic role in promoting the directional migration and osteogenic differentiation of BMSCs (Wu et al, 2018).…”

“…3D printing technology for composite scaffolds is another commonly used method whose versatility makes it increasingly important in bone regeneration. The study found that IONPs-rich PLGA copolymer scaffolds prepared through the layer-by-layer assembly by 3D printing technology promoted cell adhesion and enhanced osteogenesis of rat BMSCs (Han L. et al, 2021). Saraiva's group (Saraiva et al, 2021) used 3D printing to create a polylactic acid platform loaded with HA, IONPs, and an antibiotic (minocycline) with tunable properties and a multi-stimulus response.…”

3D-printed NIR-responsive shape memory polyurethane/magnesium scaffolds with tight-contact for robust bone regeneration

“…Bone defect as a result of diseases and traffic accidents is one of the most detrimental medical issues due to its high disability and morbidity [ 1 ], of which the orthopedic surgery cases have been predicted globally to reach over 28 million by 2022 [ 2 ]. Conventional treatment for large bone defects is to use bone grafts harvested from the patients or compatible donors for bone fixation and regeneration, however, this common practice is still associated with several limitations, including unmatched shape, disease transmission, and additional morbidity [ [3] , [4] , [5] , [6] ]. Various kinds of synthetic biomaterials have been explored as bone grafts, e.g.…”